Trials / Unknown
UnknownNCT05349266
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cells Non-Hodgkin's Lymphoma(B-NHL) After Failure of Autologous CAR-T Therapy
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase I, single center study to assess the efficacy and safety of ThisCART19A in adult with Non-Hodgkins Lymphoma in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ThisCART19A | each patient will receive a dose level per body weight(kg) for only once. |
Timeline
- Start date
- 2022-03-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
- First posted
- 2022-04-27
- Last updated
- 2022-04-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05349266. Inclusion in this directory is not an endorsement.